Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children.
Ital J Pediatr
; 48(1): 142, 2022 Aug 04.
Article
in English
| MEDLINE | ID: covidwho-1974164
ABSTRACT
From March 2020 to July 2022, in Liguria region (North-West Italy) incidence of MIS-C among pediatric patients infected by SARS-CoV-2 was 38.7/100.000, which is higher than that of myocarditis after COVID-19 vaccination. In our opinion severity of MIS-C-related cardiac disease outweigh the risk of myocarditis after COVID-19 vaccine.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Systemic Inflammatory Response Syndrome
/
COVID-19 Vaccines
/
COVID-19
/
Myocarditis
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Child
/
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Ital J Pediatr
Journal subject:
Pediatrics
Year:
2022
Document Type:
Article
Affiliation country:
S13052-022-01335-1
Similar
MEDLINE
...
LILACS
LIS